Caption Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-259,800
| Closed | -$3.99M | – | 995 |
|
|
2025
Q1 | $3.99M | Buy |
259,800
+213,664
| +463% | +$3.28M | 0.04% | 69 |
|
|
2024
Q4 | $1.02M | Sell |
46,136
-138,164
| -75% | -$3.05M | 0.01% | 201 |
|
|
2024
Q3 | $3.32M | Buy |
184,300
+141,700
| +333% | +$2.55M | 0.05% | 60 |
|
|
2024
Q2 | $692K | Buy |
+42,600
| New | +$692K | 0.01% | 177 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 882 |
|
|
2023
Q4 | – | Sell |
-369,461
| Closed | -$3.77M | – | 855 |
|
|
2023
Q3 | $3.77M | Buy |
369,461
+13,471
| +4% | +$137K | 0.06% | 40 |
|
|
2023
Q2 | $2.68M | Buy |
+355,990
| New | +$2.68M | 0.05% | 58 |
|
|
2023
Q1 | – | Sell |
-410,000
| Closed | -$3.74M | – | 803 |
|
|
2022
Q4 | $3.74M | Sell |
410,000
-472,115
| -54% | -$4.31M | 0.06% | 36 |
|
|
2022
Q3 | $7.12M | Buy |
882,115
+51,627
| +6% | +$417K | 0.1% | 10 |
|
|
2022
Q2 | $6.25M | Buy |
830,488
+243,500
| +41% | +$1.83M | 0.09% | 39 |
|
|
2022
Q1 | $5.51M | Sell |
586,988
-213,012
| -27% | -$2M | 0.07% | 66 |
|
|
2021
Q4 | $6.41M | Buy |
+800,000
| New | +$6.41M | 0.07% | 74 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 907 |
|
|
2021
Q2 | – | Sell |
-6,000
| Closed | -$69K | – | 793 |
|
|
2021
Q1 | $69K | Buy |
+6,000
| New | +$69K | ﹤0.01% | 336 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 631 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 562 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 519 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 432 |
|
|
2019
Q1 | – | Sell |
-261,602
| Closed | -$4.03M | – | 371 |
|
|
2018
Q4 | $4.03M | Buy |
+261,602
| New | +$4.03M | 0.32% | 17 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 364 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 196 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 133 |
|